MAPT and synucleinopathy: It is worthy of note that in AD, CSF tau levels are elevated from the earliest phases of the disease (36, 37) except for the subgroups of patients with the concomitant alpha-synucleinopathy, i.e., Dementia with Lewy Bodies (DLB) (37).